AIL
BMY icon

AGF Investments LLC’s Bristol-Myers Squibb BMY Stock Holding History

AGF Investments LLC’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1.7M Buy
23,897
+11,636
+95% +$844K 0.16% 39
2022
Q2 		$944K Sell
12,261
-459
-4% -$35K 0.09% 108
2022
Q1 		$929K Sell
12,720
-4,003
-24% -$269K 0.08% 90
2021
Q4 		$1.04M Buy
16,723
+13,899
+492% +$815K 0.09% 43
2021
Q3 		$167K Sell
2,824
-171
-6% -$11.3K 0.02% 299
2021
Q2 		$200K Buy
2,995
+1
+0% +$65 0.02% 296
2021
Q1 		$189K Sell
2,994
-2,004
-40% -$125K 0.02% 281
2020
Q4 		$310K Sell
4,998
-222
-4% -$13.7K 0.04% 266
2020
Q3 		$315K Sell
5,220
-25,324
-83% -$1.52M 0.04% 270
2020
Q2 		$1.8M Sell
30,544
-13,564
-31% -$811K 0.18% 64
2020
Q1 		$2.46M Sell
44,108
-4,400
-9% -$269K 0.32% 30
2019
Q4 		$3.11M Buy
48,508
+37,830
+354% +$2.17M 0.58% 29
2019
Q3 		$541K Buy
10,678
+3,095
+41% +$145K 0.13% 151
2019
Q2 		$344K Buy
7,583
+3,915
+107% +$182K 0.07% 198
2019
Q1 		$175K Sell
3,668
-72,978
-95% -$3.64M 0.04% 348
2018
Q4 		$3.98M Buy
76,646
+3,966
+5% +$213K 0.55% 46
2018
Q3 		$4.51M Buy
72,680
+12,569
+21% +$746K 0.57% 47
2018
Q2 		$3.33K Sell
60,111
-5,214
-8% -$282K 0.38% 65
2018
Q1 		$4.13M Sell
65,325
-11,455
-15% -$737K 0.7% 37
2017
Q4 		$4.71M Buy
76,780
+14,520
+23% +$908K 0.81% 40
2017
Q3 		$3.97M Buy
62,260
+13,127
+27% +$766K 0.88% 35
2017
Q2 		$2.74M Buy
49,133
+2,958
+6% +$161K 0.63% 42
2017
Q1 		$2.51M Buy
46,175
+2,825
+7% +$155K 0.63% 40
2016
Q4 		$2.53M Buy
+43,350
New +$2.37M 0.67% 37

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AGF Investments LLC's BMY Position: Q3 2022 in Review

AGF Investments LLC increased its Bristol-Myers Squibb (BMY) stake by 95% in Q3 2022, buying an estimated $844K and bringing the position to 23,897 shares worth $1.7M. The position accounts for 0.16% of the portfolio, ranked #39.

AGF Investments LLC first reported a position in BMY in Q4 2016 and has held it in 24 quarters since. The position peaked at $4.71M in Q4 2017. 2,470 funds tracked by Wall St. Rank hold BMY as of Q3 2022.

  • AGF Investments LLC held 23,897 shares of Bristol-Myers Squibb worth $1.7M as of Q3 2022.
  • AGF Investments LLC bought 11,636 Bristol-Myers Squibb shares in Q3 2022, an estimated $844K.
  • Bristol-Myers Squibb made up 0.16% of AGF Investments LLC's portfolio in Q3 2022, its #39 holding.
  • AGF Investments LLC first reported a position in Bristol-Myers Squibb in Q4 2016 and has held it in 24 quarters since.
  • AGF Investments LLC's Bristol-Myers Squibb position peaked at $4.71M in Q4 2017.
  • 2,470 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.

Based on AGF Investments LLC's 13F filing for Q3 2022, filed 10 Nov 2022.